|
Volumn 348, Issue , 2014, Pages
|
Roche and Novartis colluded over wet AMD drugs, says Italian regulator.
a
a
BMJ
*
(United Kingdom)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
DRUG INDUSTRY;
EXUDATIVE MACULAR DEGENERATION;
HUMAN;
ITALY;
LEGAL ASPECT;
NOTE;
OFF LABEL DRUG USE;
ANGIOGENESIS INHIBITORS;
DRUG INDUSTRY;
HUMANS;
ITALY;
OFF-LABEL USE;
WET MACULAR DEGENERATION;
|
EID: 84897943388
PISSN: None
EISSN: 17561833
Source Type: None
DOI: 10.1136/bmj.g2006 Document Type: Note |
Times cited : (11)
|
References (0)
|